Avery Biomedical Devices, Inc. is a company developing a Breathing Pacemaker System. The system is a phrenic nerve stimulator, also called a diaphragm pacemaker. It consists of surgically implanted receivers and electrodes mated to an external transmitter by antennas worn over the implanted receivers. Phrenic pacing provides ventilatory support for patients with chronic respiratory insufficiency whose diaphragm, lungs, and phrenic nerves have residual function.
The Avery Breathing Pacemaker System has received premarket approval from the US Food and Drug Administration (FDA) and Certification Marking (CE) to be sold in the European Economic Area.
The company is located in Commack, New York on Long Island approximately 50 miles east of New York City. In July 2015, Dr. Dilys Gore, Tony Martins and Linda Towler (CEO), three long-time employees of Avery Biomedical Devices, purchased majority ownership of the company from the Estate of Claire Dobelle.